This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre Hospitalier Régional Universitaire De Besançon, Etablissement Francais Du Sang, Institut National De La Sante Et De La Recherche Medicale. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 29 
1 out of 17 
Years Active: 2026
Title: Francine Garnache-Ottou: Inventor in Antibody and Cell Therapy
Introduction
Francine Garnache-Ottou is an inventor based in Besançon, France. Her patent work includes research on CD123-targeted antibodies and chimeric antigen receptor (CAR) T-cell technologies.
Latest Patents
Garnache-Ottou is associated with one patent: “Anti-CD123 Antibodies, Anti-CD123 Chimeric Antigen Receptors and Anti-CD123 Chimeric Antigen Receptor T Cells.” The invention concerns approaches for targeting CD123 using antibodies and engineered immune cells.
Career Highlights
Her work is associated with Université de Franche-Comté and the French National Institute of Health and Medical Research (INSERM). These institutions are connected with research and development in health and biomedical science.
Collaborations
Garnache-Ottou’s listed collaborators include Christophe Ferrand and Fanny Angelot-Delettre. Their shared work reflects collaboration in research related to CD123-targeted therapies.
Conclusion
Francine Garnache-Ottou’s patent activity highlights her contribution to research on CD123-targeted antibodies and CAR T-cell technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile